Insulet Gross Profit 2010-2024 | PODD

Insulet annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Insulet gross profit for the quarter ending December 31, 2024 was $0.431B, a 19.3% increase year-over-year.
  • Insulet gross profit for the twelve months ending December 31, 2024 was $1.446B, a 24.64% increase year-over-year.
  • Insulet annual gross profit for 2024 was $1.446B, a 24.64% increase from 2023.
  • Insulet annual gross profit for 2023 was $1.16B, a 43.98% increase from 2022.
  • Insulet annual gross profit for 2022 was $0.806B, a 7.11% increase from 2021.
Insulet Annual Gross Profit
(Millions of US $)
2024 $1,446
2023 $1,160
2022 $806
2021 $752
2020 $582
2019 $480
2018 $370
2017 $277
2016 $211
2015 $133
2014 $127
2013 $112
2012 $92
2011 $67
2010 $44
2009 $18
Insulet Quarterly Gross Profit
(Millions of US $)
2024-12-31 $431
2024-09-30 $377
2024-06-30 $331
2024-03-31 $307
2023-12-31 $361
2023-09-30 $293
2023-06-30 $265
2023-03-31 $241
2022-12-31 $217
2022-09-30 $188
2022-06-30 $190
2022-03-31 $210
2021-12-31 $213
2021-09-30 $189
2021-06-30 $183
2021-03-31 $168
2020-12-31 $161
2020-09-30 $152
2020-06-30 $143
2020-03-31 $127
2019-12-31 $134
2019-09-30 $123
2019-06-30 $116
2019-03-31 $107
2018-12-31 $110
2018-09-30 $102
2018-06-30 $82
2018-03-31 $76
2017-12-31 $80
2017-09-30 $74
2017-06-30 $65
2017-03-31 $59
2016-12-31 $61
2016-09-30 $56
2016-06-30 $50
2016-03-31 $44
2015-12-31 $42
2015-09-30 $32
2015-06-30 $31
2015-03-31 $29
2014-12-31 $21
2014-09-30 $38
2014-06-30 $36
2014-03-31 $33
2013-12-31 $33
2013-09-30 $27
2013-06-30 $27
2013-03-31 $25
2012-12-31 $25
2012-09-30 $24
2012-06-30 $22
2012-03-31 $20
2011-12-31 $20
2011-09-30 $19
2011-06-30 $15
2011-03-31 $14
2010-12-31 $14
2010-09-30 $12
2010-06-30 $10
2010-03-31 $8
2009-12-31 $7
2009-09-30 $6
2009-06-30 $3
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $18.083B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.138B 28.03
Boston Scientific (BSX) United States $152.812B 38.26
Stryker (SYK) United States $145.981B 30.52
EssilorLuxottica (ESLOY) France $128.807B 0.00
Medtronic (MDT) Ireland $107.246B 15.66
Lonza Group Ag (LZAGY) Switzerland $49.937B 0.00
Haleon (HLN) United Kingdom $47.673B 27.10
ResMed (RMD) United States $35.644B 26.77
GE HealthCare Technologies (GEHC) United States $32.281B 15.33
Agilent Technologies (A) United States $30.991B 20.47
Terumo (TRUMY) Japan $28.175B 0.00
Koninklijke Philips (PHG) Netherlands $22.624B 16.26
Zimmer Biomet Holdings (ZBH) United States $18.817B 12.09
Baxter (BAX) United States $16.011B 11.95
Smith & Nephew SNATS (SNN) United Kingdom $12.408B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $7.962B 0.00
Bio-Rad Laboratories (BIO) United States $6.751B 22.82
Lantheus Holdings (LNTH) United States $5.509B 14.04
Prestige Consumer Healthcare (PBH) United States $4.312B 19.21
Perrigo (PRGO) Ireland $3.684B 9.34
ICU Medical (ICUI) United States $3.516B 25.93
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.417B 14.88
Envista Holdings (NVST) United States $3.012B 25.03
QuidelOrtho (QDEL) United States $2.459B 16.96
GN Store Nord (GNNDY) Denmark $2.020B 16.73
LeMaitre Vascular (LMAT) United States $1.841B 41.16
AtriCure (ATRC) United States $1.544B 0.00
Neogen (NEOG) United States $1.300B 16.64
Green Thumb Industries (GTBIF) United States $1.234B 27.76
Kestra Medical Technologies (KMTS) United States $1.162B 0.00
AdaptHealth (AHCO) United States $1.130B 11.47
BioLife Solutions (BLFS) United States $1.062B 0.00
InMode (INMD) Israel $0.990B 9.06
Phibro Animal Health (PAHC) United States $0.901B 11.53
Evolus (EOLS) United States $0.651B 0.00
CeriBell (CBLL) United States $0.616B 0.00
Curaleaf Holdings (CURLF) Canada $0.592B 0.00
Owens & Minor (OMI) United States $0.540B 4.48
Valneva SE (VALN) France $0.534B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.526B 0.00
Tilray Brands (TLRY) Canada $0.445B 0.00
Cresco Labs (CRLBF) United States $0.405B 0.00
Surmodics (SRDX) United States $0.389B 0.00
Omeros (OMER) United States $0.368B 0.00
VAREX IMAGING (VREX) United States $0.356B 13.11
SNDL (SNDL) Canada $0.344B 0.00
Capricor Therapeutics (CAPR) United States $0.318B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanara MedTech (SMTI) United States $0.288B 0.00
Sanuwave Health (SNWV) United States $0.270B 0.00
Aurora Cannabis (ACB) Canada $0.267B 47.50
Verano Holdings (VRNOF) United States $0.266B 0.00
Cerus (CERS) United States $0.260B 0.00
ZimVie (ZIMV) United States $0.256B 11.63
Viemed Healthcare (VMD) United States $0.254B 21.40
Canopy Growth (CGC) Canada $0.246B 0.00
Quanterix (QTRX) United States $0.214B 0.00
Biote (BTMD) United States $0.205B 5.75
OraSure Technologies (OSUR) United States $0.194B 0.00
High Tide (HITI) Canada $0.193B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.25
TriSalus Life Sciences (TLSI) United States $0.167B 0.00
Brainsway (BWAY) Israel $0.167B 52.18
FitLife Brands (FTLF) United States $0.149B 18.33
Organigram Global (OGI) Canada $0.149B 0.00
Jin Medical (ZJYL) China $0.130B 0.00
Exagen (XGN) United States $0.111B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Jushi Holdings (JUSHF) United States $0.080B 0.00
Agape ATP (ATPC) $0.078B 0.00
Fonar (FONR) United States $0.078B 10.91
Veru (VERU) United States $0.076B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.064B 0.00
United Health Products (UEEC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Apyx Medical (APYX) United States $0.045B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.040B 58.50
Safety Shot (SHOT) United States $0.037B 0.00
United-Guardian (UG) United States $0.037B 12.74
Nephros (NEPH) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00